Biochemical characteristics and regulation of brain alpha 2-adrenoceptors.
D000316:Adrenergic alpha-Agonists / Q000378:metabolism / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D003000:Clonidine / Q000031:analogs & derivatives / Q000378:metabolism; D004837:Epinephrine / Q000502:physiology; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D006973:Hypertension / Q000378:metabolism; D008746:Methylazoxymethanol Acetate / Q000031:analogs & derivatives / Q000494:pharmacology; D016627:Oxidopamine; D010625:Phenylethanolamine N-Methyltransferase / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013045:Species Specificity; D013569:Synapses / Q000378:metabolism; D014018:Tissue Distribution; D015016:Yohimbine / Q000378:metabolism
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D006892:Hydroxydopamines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D015016:Yohimbine; D008746:Methylazoxymethanol Acetate; C016986:apraclonidine; D016627:Oxidopamine; D010625:Phenylethanolamine N-Methyltransferase; C030667:methylazoxymethanol; D003000:Clonidine; D004837:Epinephrine